COPAXONE(Glatiramer)
Generic Name and Formulations:

Glatiramer acetate 20mg/mL, 40mg/mL; soln for SC inj; contains mannitol; preservative-free.

Company:

Teva Neuroscience
Indications for COPAXONE:

To reduce the frequency of relapses in patients with relapsing-remitting multiple sclerosis, including those who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

Adult:

Supervise 1st dose. Rotate inj sites (arms, abdomen, hips, thighs). ≥18yrs: 20mg SC once daily or 40mg SC three times weekly (at least 48hrs apart). The 20mg/mL and 40mg/mL injections are not interchangeable.

Children:

<18yrs: not recommended.

Warnings/Precautions:

Not for IV inj. Pregnancy (Cat.B). Nursing mothers.

Pharmacological Class:

Immunomodulator.

Adverse Reactions:

Inj site and post-inj reactions, vasodilatation, rash, dyspnea, chest pain, asthenia, infection, pain, nausea, arthralgia, anxiety, hypertonia; rare: lipoatrophy, skin necrosis, modified immune response.

How Supplied:

Single-use prefilled syringes 20mg/mL—30; 40mg/mL—12